Clinical Trial Update: Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TBI-1501 in relapsed or refractory acute lymphoblastic leukemia (adult), currently in Phase 1/Phase 2 and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• TBI-1501

Snippet

Sponsor: Takara Bio Inc. | Conditions: Lymphoblastic Leukemia, Acute Adult | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING